انت هنا الان : شبكة جامعة بابل > موقع الكلية > نظام التعليم الالكتروني > مشاهدة المحاضرة
الكلية كلية طب حمورابي
القسم الكلية ذات القسم الواحد
المرحلة 3
أستاذ المادة نيران كاظم فرهود الربيعي
12/01/2017 18:07:56
Mumps virus Important properties • It belongs to paramyxoviruses. • ssRNA genome. • Helical nucleocapsid. • Enveloped. • It has spikes: three types of antigens H(for attachment), N(for release) and F (fusion antigen for entry of virus). • It has one serotype
Source and transmission • Humans are a natural host. • Mumps virus is highly contagious. It is transmitted via respiratory droplets, salivary secretion, or urine (viruria is common).
Pathogenesis • The virus infects epithelial cells of URT and then spreads through blood to salivary glands, primarily parotid glands, testes, ovaries, pancreas, kidney, and in some cases to CNS(meninges). • Alternatively, the virus may ascend from buccal mucosa up Stensen duct to parotid glands.
Clinical Finding • Incubation period is 18-20 days; it causes mumps characterized by swelling of parotid gland either unilateral or bilateral, that painful. Parotitis occurs in less than 50% of infection. Fever , males ,malaise, anorexia are associated with the disease. • 2 complication; orchitis (testes inflammation) in males, if bilateral of testes can result in sterility. Another complication is meningitis. • It is a common disease in school-age children. Most cases occur in winter. 30% of children have the sub-clinical infection. • Lifelong immunity occurs in infected persons. • Maternal Abs pass the placenta and provide protection during first 6 months of life.
Laboratory Diagnosis • Detection of S (soluble)-antigen (NP) by CFT indicate a current infection. • Detection of V( viral)-antigen indicates past infection. Also, skin test can be used to detect the previous infection.
Control • No specific antiviral therapy. • MMR-vaccine (combined: mumps, measles and rubella) is given for children at 15 months.
------------------------------------------------------------------------------------------------------------- Measles virus Important properties • It belongs to paramyxoviruses. • ssRNA genome. • Shape of the virus is spherical and helical symmetry. • Enveloped. • It has spikes: two types of antigens H and F. • It has single serotype.
Source and transmission • Humans are a natural host. • It is transmitted by inhalation of respiratory droplets during coughing. • It is high communicable with 90% infection rate.
Pathogenesis The virus initially infects epithelial cells of trachea and bronchi of respiratory tract and then spread and multiplies in LNs. then the virus enters blood (viremia) and disseminated to distant sites throughout the body , including skin and mucosa. Maculopapular rash is appear due to cell-mediated immunity attack by cytotoxic T-cells on measles-infected vascular endothelial cells in the skin. Antibodies may play role in vasculitis. Formation of multi-nucleated giant cells, resulting from the fusion of infected cells with neighboring uninfected cells (due to F-protein), is characterized pathogenic feature of measles infection.The virus evades neutralizing Abs by H-antigen or it spreads directly cell to cell by F-protein. It also evades immune recognition by it ability to induce temporary general immuno-suppression.
Clinical Finding • Incubation period (10-14 days), It causes measles, the prodromal phase of disease characterized by fever, runny nose, cough, coryza, and conjunctivitis (photophobia). • After few days, 2-3 , Small white spots on inflamed buccal mucosa membrane (koplike spots) appear inside cheek, followed by maculopapular rash appearing first on a head, and spreading to a trunk. • Most cases occur in children. • Complication particularly in mal-nutrition children and immuno-compromised patients: like otitis media, pneumonia, deafness, and encephalitis. In pregnant women may lead to stillbirth. • One infection confers lifelong immunity.
Laboratory Diagnosis • Serological tests like ELISA. • Genetic technique like PCR.
Control • Non-specific therapy, but sensitive to ribavirin. • MMR vaccine is given to children at 15 months of age.
******************************************************************
Good Luck
المادة المعروضة اعلاه هي مدخل الى المحاضرة المرفوعة بواسطة استاذ(ة) المادة . وقد تبدو لك غير متكاملة . حيث يضع استاذ المادة في بعض الاحيان فقط الجزء الاول من المحاضرة من اجل الاطلاع على ما ستقوم بتحميله لاحقا . في نظام التعليم الالكتروني نوفر هذه الخدمة لكي نبقيك على اطلاع حول محتوى الملف الذي ستقوم بتحميله .
الرجوع الى لوحة التحكم
|